Skip to main content
OpenTrials

Clinical trial condition

Triple Negative Breast Neoplasms

Explore clinical trials studying Triple Negative Breast Neoplasms. Study availability and eligibility vary by location and protocol.

818 public trials 296 recruiting studies
Refine in advanced search Browse all conditions

Triple Negative Breast Neoplasms trial results

Recruiting

Pembrolizumab + Paclitaxel +/- Bevacizumab for Triple-negative Breast Cancer

NCT06976944

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • National Hospital Organization Nagoya Medical Center Nagoya, Aichi-ken, Japan
  • Nagoya University Hospital Nagoya, Aichi-ken, Japan
  • Nagoya City University Hospital Nagoya, Aichi-ken, Japan
  • National Cancer Center Hospital East Kashiwa-shi, Chiba, Japan
View all 14 locations
View Trial Details
Recruiting

A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

NCT07020117

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +20 more
Locations
  • City of Hope Duarte, California, United States
  • Hoag Memorial Hospital Presbyterian Irvine, California, United States
  • Biogenix Molecular, LLC Miami, Florida, United States
  • Advent Health Medical Group Radiation Oncology at Central Florida Orlando, Florida, United States
View Trial Details
Recruiting

Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers

NCT06562192

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +26 more
Locations
  • Uni of Alabama at Birmingham Birmingham, Alabama, United States
  • University of California LA Los Angeles, California, United States
  • Stanford University Medical Center Palo Alto, California, United States
  • Mayo Clinic Jacksonville Jacksonville, Florida, United States
View all 29 locations
View Trial Details
Recruiting

Phase II Trial of Ivonescimab in Combination With Carboplatin + Docetaxel in Patients With Early-Stage Triple Negative Breast Cancer

NCT07017673

Conditions
Breast Diseases, Breast Neoplasms, Early Stage Triple-Negative Breast Carcinoma, +7 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Cedars-Sinai Medical Center Beverly Hills Los Angeles, California, United States
  • Huntington Cancer Center, an Affiliate of CS Cancer Pasadena, California, United States
  • Hunt Cancer Institute, an Affiliate of CS Cancer Torrance, California, United States
View Trial Details
Recruiting

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

NCT07115043

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +58 more
Locations
  • Research Site Grand Rapids, Michigan, United States
  • Research Site St Louis, Missouri, United States
  • Research Site Pittsburgh, Pennsylvania, United States
  • Research Site Houston, Texas, United States
View all 13 locations
View Trial Details
Recruiting

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

NCT05579366

Conditions
Adenoma, Adnexal Diseases, Breast Adenocarcinoma, +49 more
Locations
  • USOR HonorHealth Phoenix, Arizona, United States
  • USOR Arizona Oncology Associates Tucson, Arizona, United States
  • University of California Los Angeles Medical Center Los Angeles, California, United States
  • University of California, San Diego; Moores Cancer Center San Diego, California, United States
View all 66 locations
View Trial Details
Recruiting

First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer

NCT06799065

Conditions
Adnexal Diseases, Advanced Solid Tumors, Breast Cancer Recurrent, +22 more
Locations
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • SCRI Oncology Partners Nashville, Tennessee, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

NCT04895709

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Diseases, +56 more
Locations
  • Community Cancer Institute Clovis, California, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • University of Iowa Iowa City, Iowa, United States
View all 47 locations
View Trial Details

Related conditions